European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025
Impact of Age Difference Between Donor and Recipient on Intermediate- and Long-Term Survival in Lung Transplant Recipients: A Cohort Study Based on Recipient Age Stratification.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
He Wei, Wang Zhiwei, Luo Caikang, Zhang Jiaqin, Lin Yanwei, Pan Yining, He Junjie, Lan Xiaoqing, Yang Chao, Peng Guilin, Shi Jiang, Xu Xin
Аннотация
OBJECTIVES: The impact of donor-recipient age difference on survival after lung transplantation (LTx) remains unclear. This study investigates effects in different recipient age groups to optimize donor-recipient matching.
METHODS: Analysing United Network for Organ Sharing (UNOS) data (2005-2015), we stratified adult first-time LTx recipients into 3 age strata (18-40, 40-60, 60-80 years). Donor-recipient age difference (Δ = donor age-recipient age) was classified into Δ < 0 and Δ ≥ 0 groups; the 60-80 stratum was further divided into Δ < -10 and Δ < 0 to ≤ -10 groups. Outcomes included 5-year (primary) and 10-year patient and graft survival, with subgroup analyses by underlying pulmonary disease.
RESULTS: Δ < 0 was associated with significantly better 5-year graft survival in the 18-40 and 40-60 strata (adjusted hazard ratio [HR]: 1.21 [1.02-1.44], P = .031 in 18-40; 1.19 [1.05-1.35], P = .006 in 40-60). Among recipients aged 60-80 (Δ < 0 only), Δ<-10 showed superior 5-year patient survival compared to Δ < 0 to ≤ -10 (adjusted HR 1.23 [1.10-1.37], P < .001). Secondary analyses showed in 40-60, Δ < 0 had better 10-year patient survival (adjusted HR: 1.14 [1.02-1.27], P = .017); and in 60-80, Δ<-10 remained favourable (adjusted HR: 1.12 [1.02-1.23], P = .015). Subgroup analyses confirmed greater benefit younger donors in cystic fibrosis recipients aged 18-40 and 40-60, and idiopathic pulmonary fibrosis recipients aged 60-80.
CONCLUSIONS: Younger donors correlate with better intermediate- and long-term post-transplant survival, particularly for graft survival, supporting individualized preferential matching when clinically feasible.
METHODS: Analysing United Network for Organ Sharing (UNOS) data (2005-2015), we stratified adult first-time LTx recipients into 3 age strata (18-40, 40-60, 60-80 years). Donor-recipient age difference (Δ = donor age-recipient age) was classified into Δ < 0 and Δ ≥ 0 groups; the 60-80 stratum was further divided into Δ < -10 and Δ < 0 to ≤ -10 groups. Outcomes included 5-year (primary) and 10-year patient and graft survival, with subgroup analyses by underlying pulmonary disease.
RESULTS: Δ < 0 was associated with significantly better 5-year graft survival in the 18-40 and 40-60 strata (adjusted hazard ratio [HR]: 1.21 [1.02-1.44], P = .031 in 18-40; 1.19 [1.05-1.35], P = .006 in 40-60). Among recipients aged 60-80 (Δ < 0 only), Δ<-10 showed superior 5-year patient survival compared to Δ < 0 to ≤ -10 (adjusted HR 1.23 [1.10-1.37], P < .001). Secondary analyses showed in 40-60, Δ < 0 had better 10-year patient survival (adjusted HR: 1.14 [1.02-1.27], P = .017); and in 60-80, Δ<-10 remained favourable (adjusted HR: 1.12 [1.02-1.23], P = .015). Subgroup analyses confirmed greater benefit younger donors in cystic fibrosis recipients aged 18-40 and 40-60, and idiopathic pulmonary fibrosis recipients aged 60-80.
CONCLUSIONS: Younger donors correlate with better intermediate- and long-term post-transplant survival, particularly for graft survival, supporting individualized preferential matching when clinically feasible.